New drug cocktail aims to cut Post-Surgery pain in half

NCT ID NCT07523321

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving a combination of two drugs, dexmedetomidine and esketamine, during and after spinal surgery can reduce moderate-to-severe pain in the first three days after the operation. About 274 adults aged 40 to 80 having spine surgery will be randomly assigned to receive the drug combo or a placebo. The goal is to see if this approach leads to better pain control and fewer side effects than current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dexmedetomidine and esketamine (drug combination)
What this could lead to
If it works, this could offer a better way to manage pain after spinal surgery, reducing the need for strong opioids and improving recovery.
What could go wrong
This is a Phase 4 trial, but it's still early and small (274 people). The drug combo may not work better than standard care, and side effects like low heart rate or confusion are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEXMEDETOMIDINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peking University First Hospital

    Beijing, Beijing Municipality, 100034, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.